NCT00190931View on ClinicalTrials.gov

A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder

PHASE4CompletedINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

July 31, 2005

Conditions

Attention Deficit Disorder With Hyperactivity

Interventions

DRUG

Atomoxetine Hydrochloride

DRUG

placebo

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Columbia

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00190931 - A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder | Biotech Hunter | Biotech Hunter